On March 28, 2021, the project "Health China 2030" - standardized diagnosis and treatment training and inter hospital communication in tumor field 2021 "sponsored by the national health and Health Commission medical and health science and Technology Development Research Center was officially launched in Beijing. The project has established grass-roots training bases in many places throughout the country, organized experts to carry out online and offline inter hospital exchanges and tour meetings, and carried out clinical guidance and academic front-line transmission of tumor treatment in grass-roots hospitals, improved the basic doctors' cognition and understanding of the latest treatment methods of tumor, and provided more standardized and high-quality cancer prevention and treatment services for the majority of patients. 21 basic hospitals were awarded as "2021 training base for promoting appropriate technology for tumor standardized diagnosis and treatment", and will carry out diagnosis and treatment training and inter hospital exchange activities in the region where the project is located. Meanwhile, the project kick-off meeting invited well-known experts in the field of tumor to conduct in-depth interpretation and view sharing for standardized diagnosis and treatment training in tumor area.
Zhao Kaili, director of evaluation and achievement transformation division of the Research Center for medical and health science and technology development of the national health and Health Commission, said: "in order to implement the 2030 plan for health China, improve the ability of health technicians in diagnosis and treatment of diseases in the field of cancer, realize early detection, early treatment and early recovery of tumors, and solve the current situation of uneven distribution of high-quality medical resources and relatively insufficient basic medical service capacity in China, Our center has launched and hosted the 2021 standardized diagnosis and treatment training and inter hospital exchange project of Health China 2030 cancer health plan, which will contribute to promoting the communication of oncology and the construction of primary oncology disciplines, promoting the transformation of scientific and technological achievements, providing standardized and standardized medical services for primary tumor patients, and benefiting more tumor patients
Tumor is a serious public health problem which seriously threatens the health of our people. In 2020, China has 4.57 million new cancers, ranking the first in the world, of which 550000 new colorectal cancer patients, accounting for 12.2% of the newly diagnosed cancer in China, that is, less than one of the 8 patients is colorectal cancer. The incidence rate of colon cancer has increased significantly. Most patients have been diagnosed with advanced and metastatic diseases at the time of diagnosis, which has brought great challenges to treatment and prognosis. At present, the advanced colorectal cancer is mainly treated with drugs, which improves the prognosis and quality of life of patients. However, once the tumor recurres or progresses, the second or third-line treatment effect is often poor.
Standardized diagnosis and treatment is the basic guarantee for patients to get good treatment effect. Professor Song Qibin, people's Hospital of Wuhan University and Professor liyunfeng of Yunnan cancer hospital will give an opening speech and introduce the meeting. The academic link of the meeting focuses on the difficulties and selection of the three-line treatment of advanced colorectal cancer Professor zhengtongsen of Affiliated Cancer Hospital has carried out in-depth interpretation of the guidance for colorectal cancer diagnosis and treatment, in order to guide clinical practice through the guidance, and further promote the communication and integration of multi disciplines and standardized diagnosis and treatment
Professor Wu Hongyang, the First Affiliated Hospital of Anhui Medical University, shared the status quo of advanced colorectal cancer treatment. After the failure of traditional first-line and second-line standard treatment, the effective three-line treatment methods are limited. In recent years, with the application of molecular targeted therapy, tumor angiogenesis inhibitors with high selectivity are expected to extend their overall life span, meet the needs of the third line treatment of advanced colorectal cancer, so that the patients will benefit. Professor Zhang Xuan of Yunnan cancer hospital has discussed with many domestic experts in the field of cancer in the MDT experience exchange and sharing section on the topics of diagnosis and treatment norms, three-line treatment strategies for advanced colorectal cancer and multidisciplinary diagnosis and treatment.
The basic medical and health institutions are the important carriers of basic medical and public health services in China. The "strong grass-roots" has always been the key strategic measure of "healthy China". The number of doctors in the grass-roots medical institutions has increased year by year, reaching 1.437 million by the end of 2019. To make more grassroots doctors engaged in tumor treatment improve their understanding and application of new cancer treatment methods under the guidance of "Health China 2030" plan, which will further improve the level of primary-level tumor treatment, and make patients in basic hospitals get more standardized and high-quality tumor treatment.
"2021 standardized diagnosis and treatment training and inter hospital exchange" project will carry out offline inter hospital exchanges, online inter hospital exchanges and offline tour conferences in accordance with local conditions, in combination with the current situation of tumor diagnosis and treatment level in different regions, and more widely cover the grassroots clinicians, promote the standardization of primary tumor diagnosis and treatment, and help the "healthy China 2030" target be reached as soon as possible.
Reference address:
https://www.mdweekly.com.cn/html/xinwen/tebiebaodao/2021/0328/33358.html
